Exclusive Distribution Agreement Sample Contracts

RECITALS
Exclusive Distribution Agreement • May 17th, 2007 • Ingen Technologies, Inc. • Miscellaneous manufacturing industries • California
SECOND AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • April 21st, 2021 • Kaival Brands Innovations Group, Inc. • Blank checks • Florida

THIS SECOND AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is entered into as of April 20, 2021 (the “Effective Date”) by and between BIDI VAPOR, LLC, a Florida limited liability company (“Manufacturer”), and KAIVAL BRANDS INNOVATIONS GROUP, INC., a Delaware corporation (“Distributor”). Manufacturer and Distributor are each referred to herein as a “Party” and collectively, the “Parties.”

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • February 22nd, 2016 • Blow & Drive Interlock Corp • Motor vehicle parts & accessories • Arizona

THIS EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement” or this “Exclusive Distribution Agreement) is entered into effective as of 01/11/2016 (the “Effective Date”) by and between Blow & Drive Interlock Corporation (and any of its subsidiaries) (“Supplier”) having an address at 137 South Robertson Blvd, Suite 129, Beverly Hills, CA 90211 and dba BLOW & DRIVE HOUSTON

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • May 8th, 2007 • Pro Elite Inc • Services-amusement & recreation services

Agreement made as of this 8th day of November, 2006, between PRO ELITE, INC., 12100 Wilshire Boulevard, Suite 800, Los Angeles, CA 90025 (hereinafter referred to as “Licensor”) and SHOWTIME NETWORKS INC., 1633 Broadway, New York, New York 10019 (hereinafter referred to as “SNI”) concerning the staging, television production and distribution of mixed martial arts programs as more fully set forth below.

Contract
Exclusive Distribution Agreement • January 30th, 2009 • Meridian Co LTD • Surgical & medical instruments & apparatus

***Denotes certain parts that have not been disclosed and have been filed separately with the Secretary, Securities and Exchange Commission, and is subject to a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations • England

This EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of August 2, 2012 (the “Effective Date”) by and between Kamada Ltd., an Israeli corporation (collectively with its Affiliates, “Kamada”), whose principal office is at Science Park, Kiryat Weizmann, 7 Sapir Street, Ness Ziona 74140, Israel, and Chiesi Farmaceutici S.p.A (“Chiesi”), an Italian corporation whose registered office is at Via Palermo 26/A, 43122 Parma, Italy.

DATED 24th March 2009 NITEC PHARMA AG AND MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • October 21st, 2010 • Horizon Pharma, Inc. • Pharmaceutical preparations
Contract
Exclusive Distribution Agreement • April 26th, 2023 • CASI Pharmaceuticals, Inc. • Pharmaceutical preparations

Certain confidential information contained in this document, marked by brackets and *** asterisk, has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly disclosed.

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • July 27th, 2005 • Imcor Pharmaceutical Co • Pharmaceutical preparations • Tennessee

This Exclusive Distribution Agreement (“Agreement”) is made as of April 1, 2002 (the “Effective Date”), between Alliance Pharmaceutical Corp., a New York corporation, having its principal place of business at 3040 Science Park Road, San Diego, California 92121 (“Client”), and CORD Logistics, Inc., an Ohio corporation, having its principal place of business at 15 Ingram Boulevard, LaVergne, Tennessee 37086 (“CORD”).

RECITALS
Exclusive Distribution Agreement • April 4th, 2005 • Ppol Inc • Telephone & telegraph apparatus • Florida
Exclusive Distribution Agreement
Exclusive Distribution Agreement • October 30th, 2018 • Healthier Choices Management Corp. • Tobacco products • Nevada

This Exclusive Distribution Agreement (this “Agreement”), dated as of August ___, 2018 (the “Effective Date”), is entered into between Healthier Choices Management Corp., a Delaware corporation, or its assigned wholly owned subsidiary (“Seller”), and MJ Holdings Inc., a Nevada corporation, or its designee or any wholly owned subsidiary subject to approval by Seller in Seller’s sole discretion (“Distributor”, and together with Seller, the “Parties”, and each, a “Party”).

Exclusive Distribution Agreement
Exclusive Distribution Agreement • September 29th, 2020 • Slinger Bag Inc. • Services-personal services • Maryland

This Exclusive Distribution Agreement (this “Agreement”), dated as of 2020 (the “Effective Date”), is entered into between Slinger Bag Americas Inc., a Delaware corporation located at 2709 N. Rolling Road, Unit 138, Windsor Mill, MD 21244, with company registration number 0127-01-003630 and Dunlop International Europe Ltd., with its offices located at Thorncroft Manor, Thorncroft Drive, Leatherhead, England, KT22 8JB, with company registration number 00776384, a 100% owned subsidiary of Sumitomo Rubber Industries, Ltd., with its offices located at 3-6-9 Wakinohama-cho, Chuo-ku, Kobe, Hyogo 651-0072, Japan (“Distributor”), and together with SBA, the “Parties”, and each, a “Party”).

EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SOLUTIONS 2 GO INC. AND ZOO PUBLISHING, INC.
Exclusive Distribution Agreement • November 23rd, 2009 • Zoo Entertainment, Inc • Services-prepackaged software • California

The parties to this Exclusive Distribution Agreement (“Agreement”) dated August 31, 2009 (the “Effective Date”) are SOLUTIONS 2 GO Inc., a Canadian corporation (“DISTRIBUTOR”); and ZOO PUBLISHING, INC., a New Jersey corporation (“PUBLISHER”).

Contract
Exclusive Distribution Agreement • May 13th, 2022 • Waldencast Acquisition Corp. • Perfumes, cosmetics & other toilet preparations

[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item (601)(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.

WITNESSETH:
Exclusive Distribution Agreement • February 8th, 2006 • Creative Enterprises International Inc • Wholesale-groceries, general line
Exclusive Distribution Agreement
Exclusive Distribution Agreement • September 9th, 2020 • Slinger Bag Inc. • Services-personal services • Maryland

This Exclusive Distribution Agreement (this “Agreement”), dated as of 25 August 2020 (the “Effective Date”), is entered into between Slinger Bag Americas Inc., a Delaware corporation located at 2709 N. Rolling Road Unit 138, Windsor Mill, Baltimore, MD 21244, with company registration number 0127-01-003630 and Sporting Goods Specialists Limited, a company organized and existing under the laws of New Zealand located at 20C Sylvia Park Road, Mount Wellington, Auckland 1060 New Zealand and with company registration number 845050 (“Distributor”), and together with SBA, the “Parties”, and each, a “Party”).

THIS VERSION HAS BEEN MODIFIED TO OMIT CERTAIN CONFIDENTIAL INFORMATION OF VISION-SCIENCES, INC., WHICH HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....
Exclusive Distribution Agreement • March 18th, 2005 • Vision Sciences Inc /De/ • Electromedical & electrotherapeutic apparatus • New York

This Exclusive Distribution Agreement (the “Agreement”) is made as of this 29th day of December, 2004 (the “Effective Date”) by and between Vision-Sciences, Inc., a Delaware corporation (the “Company”), and Medtronic USA, Inc., a Minnesota corporation (“MDT”, and collectively with the Company, the “Parties”).

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations • New York

This EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into effective as of April 3, 2013 (the “Effective Date”) by and between INNOCOLL Pharmaceuticals Limited, an Irish corporation (collectively with its Affiliates) (“INNOCOLL”), whose principal office is at Athlone Business & Technology Park, Garrycastle, Athlone, Co. Westmeath Ireland, and Biomet 3i, LLC, (“BIOMET”), a limited liability company whose principal office is at 4555 Riverside Drive, Palm Beach Gardens, Florida 33410.

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • January 17th, 2012 • Vermillion, Inc. • In vitro & in vivo diagnostic substances

THIS EXCLUSIVE DISTRIBUTION AGREEMENT (the “Agreement”) is made and entered into the 1st day of August, 2011 (“Effective Date”), by and between Vermillion Inc., a Delaware corporation with its principal business address at 12117 Bee Caves Rd. Building III, Suite 100, Austin, TX 78738, USA (“Supplier”) and Pronto Diagnostics Ltd., an Israeli company with registered address at 19a Habarzel St., Ramat Hachayal, Tel Aviv 69710, Israel (“Distributor”).

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • August 16th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee

This Exclusive Distribution Agreement (the “Agreement”) is made as of this 1st day of July, 2010 (the “Effective Date”), between Cumberland Pharmaceuticals, Inc., a Tennessee corporation, with an address of 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203 (“Client”), and Cardinal Health 105, Inc., an Ohio corporation, with a place of business at 15 Ingram Boulevard, Suite 100, LaVergne, Tennessee, 37086 (“Cardinal Health”) each individually a (“Party”) and collectively (the “Parties”).

DATED NOVEMBER 4, 2010 HORIZON PHARMA AG AND MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • April 1st, 2011 • Horizon Pharma, Inc. • Pharmaceutical preparations
EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • April 4th, 2012 • DARA BioSciences, Inc. • Pharmaceutical preparations • England and Wales

This Exclusive Distribution Agreement (this “Agreement”) is entered into as of 29th June 2011 (the “Effective Date”), between Oncogenerix, Inc., a Nevada corporation having offices at 3069 Pignatelli Crescent, Mt. Pleasant, SC 29466 (“Oncogenerix”) and Rosemont Pharmaceuticals Limited (company number: 00924648), a company incorporated in England and Wales and having offices at Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds LS II 9XE, United Kingdom (“Rosemont”).

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • October 6th, 2017 • Erytech Pharma S.A. • Biological products, (no disgnostic substances)

• ERYtech Pharma S.A, a Societé Anonyme existing and organized under the laws of the Republic of France, having its registered head office at 60 Avenue Rockefeller, Bâtiment Adenine, 69008 Lyon, France, with a registered capital of 315.355 Euros;

THIS VERSION HAS BEEN MODIFIED TO OMIT CERTAIN CONFIDENTIAL INFORMATION OF VISION-SCIENCES, INC., WHICH HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....
Exclusive Distribution Agreement • November 14th, 2003 • Vision Sciences Inc /De/ • Electromedical & electrotherapeutic apparatus • New York

This Exclusive Distribution Agreement (the “Agreement”) is made as of this 6th day of August, 2003 by and between Vision-Sciences, Inc., a Delaware corporation with a principal office located at 9 Strathmore Road, Natick, Massachusetts 01760 (“Company”), and Medtronic Xomed, Inc., a Delaware corporation with a principal office located at 6743 Southpoint Drive North, Jacksonville, Florida 32216 (“MDTX”).

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • August 27th, 2009 • Dais Analytic Corp • Miscellaneous manufacturing industries • New York

EXCLUSIVE DISTRIBUTION AGREEMENT by and between Dais Analytic Corporation, a New York corporation (“Supplier”), 11552 Prosperous Drive, Odessa, FL USA, and Genertec America, Inc., a California corporation ("Distributor”), 805 Veterans Blvd., Suite 210, Redwood City, CA94063, USA

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • April 16th, 2021 • Big Rock Partners Acquisition Corp. • Pharmaceutical preparations • Delaware

This Exclusive Distribution Agreement (the “Agreement”) is made as of this 25th day of September 2020 (the “Effective Date”), between NeuroRx, Inc., a Delaware corporation, with a principal mailing address of 913 North Market Street, Suite 200, Wilmington, Delaware 19801 (“Client”), and Cardinal Health 105, Inc., an Ohio corporation, with a place of business at 501 Mason Road, Suite 200, La Vergne, Tennessee, 37086 (“Cardinal Health”) each individually a (“Party”) and collectively (the “Parties”).

Second Amendment to the Exclusive Distribution Agreement dated January 10, 2020
Exclusive Distribution Agreement • November 8th, 2022 • Revance Therapeutics, Inc. • Pharmaceutical preparations
SECOND AMENDMENT TO EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • September 25th, 2020 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California

This Second Amendment to the Exclusive Distribution Agreement (this “Second Amendment”) is made and entered into effective as of September 21, 2020 (the “Second Amendment Effective Date”), and is by and between Puregraft LLC, a Delaware Limited Liability Company having its primary office and place of business at 420 Steven Avenue, Suite 220, Solana Beach, CA 92075, its parent company Bimini Technologies, LLC, and any affiliate and/or subsidiaries thereto (together, “Puregraft”) and Establishment Labs S.A., a company organized under the laws of Costa Rica, having its primary office and place of business at Coyol Free Zone Building 25, Alajuela, Costa Rica (“Distributor”) (each a “Party” and collectively the “Parties”).

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • March 15th, 2007 • Bruker Biosciences Corp • Laboratory analytical instruments • Massachusetts

Agreement dated January, 1st 2002 between Bruker BioSpin GmbH, having its principal place of business at Rheinstetten, Germany (the “Manufacturer”) and Bruker Optics Inc., a Delaware corporation, having its principal place of business at Billerica, Massachusetts (the “Distributor”).

CONFIDENTIAL TREATMENT REQUESTED EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • November 15th, 2004 • Macropore Inc • Orthopedic, prosthetic & surgical appliances & supplies • California

THIS EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into effective as of the date the last party hereto signs as shown on the signature page (“Effective Date”), and is by and between MacroPore Biosurgery, Inc., a Delaware corporation (“MacroPore”), and Senko Medical Trading Co., a Japanese Corporation (“Senko”).

EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • March 9th, 2023 • DAVIS COMMODITIES LTD • Wholesale-farm product raw materials
EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • September 1st, 2010 • Cdex Inc • Measuring & controlling devices, nec • Nevada

This Exclusive Distribution Agreement (this "Agreement") is made effective as of the 20th day of August, 2010, (the "Effective Date") by and between CDEX, Inc., a Nevada Corporation ("CDEX") and the signatories below (“Signatories”):

EXCLUSIVE DISTRIBUTION AGREEMENT BY AND BETWEEN DIVINE SKIN, INC. AND “DISTRIBUTOR”
Exclusive Distribution Agreement • October 26th, 2012 • Divine Skin Inc. • Perfumes, cosmetics & other toilet preparations

This Agreement, made and entered into this 25th day of November, 2008 (the "EFFECTIVE DATE"), by and between DIVINE SKIN, INC., whose principal office is located at 1680 Meridian Ave Suite 301, Miami Beach, FL 33139 (the "MANUFACTURER"), and Cellway International Inc, whose principal office is located at 363 Van Ness Way Suite 402, Torrance, CA. 90501 (the "DISTRIBUTOR"). The Manufacturer and the Distributor are sometimes collectively referred to as the "Parties" and sometimes individually referred to as a "Party."